Skip to Content

Clinical Trial Details

SystHERs Registry

An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)


Request Additional Trial Information
Full Trial Details:

Condition: Breast Cancer
Study Type: Non-interventional
Phase: Phase IV
Study Start Date: 06/12/2012
Study Completion Date: TBD

This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC). Eligible patients will have an initial metastatic breast cancer diagnosis that has not been previously treated with systemic therapy; patients may be enrolled up to 6 months after the diagnosis. Data will be collected for up to 8 years.

NCT Number
Principal Investigator(s)
John Wallmark, MD
Genentech, Inc
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Male, Female


  • Shady Grove Adventist Aquilino Cancer Center
    9905 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6297

Clincal Trials & Research Studies

Patient Stories

We’re writing new chapters in the lives of our patients, their families and our community daily. These are their stories:

Local Health News - In Your Inbox

Join over 40k of your friends & neighbors and get the latest news about community health programs and events when you sign-up for Adventist HealthCare & You Digital.

Subscribe Today!